Annual CFF
-$500.00 K
+$1.68 M+77.09%
December 31, 2023
Summary
- As of February 7, 2025, LTRN annual cash flow from financing activities is -$500.00 thousand, with the most recent change of +$1.68 million (+77.09%) on December 31, 2023.
- During the last 3 years, LTRN annual CFF has fallen by -$24.16 million (-102.11%).
- LTRN annual CFF is now -100.79% below its all-time high of $63.42 million, reached on December 31, 2021.
Performance
LTRN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$12.00 K
+$12.00 K+100.00%
September 30, 2024
Summary
- As of February 7, 2025, LTRN quarterly cash flow from financing activities is $12.00 thousand, with the most recent change of +$12.00 thousand (+100.00%) on September 30, 2024.
- Over the past year, LTRN quarterly CFF has increased by +$12.00 thousand (+100.00%).
- LTRN quarterly CFF is now -99.98% below its all-time high of $64.29 million, reached on March 31, 2021.
Performance
LTRN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$433.30 K
+$12.00 K+2.69%
September 30, 2024
Summary
- As of February 7, 2025, LTRN TTM cash flow from financing activities is -$433.30 thousand, with the most recent change of +$12.00 thousand (+2.69%) on September 30, 2024.
- Over the past year, LTRN TTM CFF has dropped by -$433.30 thousand (-100.00%).
- LTRN TTM CFF is now -100.49% below its all-time high of $87.85 million, reached on March 31, 2021.
Performance
LTRN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
LTRN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +77.1% | +100.0% | -100.0% |
| 3 y3 years | -102.1% | +100.0% | -100.7% |
| 5 y5 years | -193.5% | -98.9% | -114.8% |
LTRN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.8% | +77.1% | -78.1% | +100.5% | -100.7% | +85.8% |
| 5 y | 5-year | -100.8% | +77.1% | -100.0% | +100.5% | -100.5% | +85.8% |
| alltime | all time | -100.8% | +77.1% | -100.0% | +100.5% | -100.5% | +85.8% |
Lantern Pharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $12.00 K(>+9900.0%) | -$433.30 K(-2.7%) |
| Jun 2024 | - | $0.00(-100.0%) | -$445.30 K(0.0%) |
| Mar 2024 | - | $54.70 K(-110.9%) | -$445.30 K(-10.9%) |
| Dec 2023 | -$500.00 K(-77.1%) | -$500.00 K(<-9900.0%) | -$500.00 K(<-9900.0%) |
| Sep 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2022 | -$2.18 M(-103.4%) | $0.00(0.0%) | -$2.18 M(-28.6%) |
| Sep 2022 | - | $0.00(0.0%) | -$3.06 M(0.0%) |
| Jun 2022 | - | $0.00(-100.0%) | -$3.06 M(0.0%) |
| Mar 2022 | - | -$2.18 M(+150.1%) | -$3.06 M(-104.8%) |
| Dec 2021 | $63.42 M | -$872.80 K(<-9900.0%) | $63.42 M(-1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $0.00(0.0%) | $64.29 M(+0.2%) |
| Jun 2021 | - | $0.00(-100.0%) | $64.19 M(-26.9%) |
| Mar 2021 | - | $64.29 M(<-9900.0%) | $87.85 M(+271.2%) |
| Dec 2020 | $23.66 M(+710.3%) | -$300.00(-99.7%) | $23.66 M(-0.0%) |
| Sep 2020 | - | -$102.80 K(-100.4%) | $23.67 M(-4.7%) |
| Jun 2020 | - | $23.66 M(>+9900.0%) | $24.84 M(+2012.5%) |
| Mar 2020 | - | $105.30 K(>+9900.0%) | $1.18 M(-59.7%) |
| Dec 2019 | $2.92 M(+445.9%) | $0.00(-100.0%) | $2.92 M(0.0%) |
| Sep 2019 | - | $1.07 M(>+9900.0%) | $2.92 M(+57.9%) |
| Jun 2019 | - | $0.00(-100.0%) | $1.85 M(0.0%) |
| Mar 2019 | - | $1.85 M | $1.85 M |
| Dec 2018 | $535.00 K | - | - |
FAQ
- What is Lantern Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for Lantern Pharma?
- What is Lantern Pharma annual CFF year-on-year change?
- What is Lantern Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Lantern Pharma?
- What is Lantern Pharma quarterly CFF year-on-year change?
- What is Lantern Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Lantern Pharma?
- What is Lantern Pharma TTM CFF year-on-year change?
What is Lantern Pharma annual cash flow from financing activities?
The current annual CFF of LTRN is -$500.00 K
What is the all time high annual CFF for Lantern Pharma?
Lantern Pharma all-time high annual cash flow from financing activities is $63.42 M
What is Lantern Pharma annual CFF year-on-year change?
Over the past year, LTRN annual cash flow from financing activities has changed by +$1.68 M (+77.09%)
What is Lantern Pharma quarterly cash flow from financing activities?
The current quarterly CFF of LTRN is $12.00 K
What is the all time high quarterly CFF for Lantern Pharma?
Lantern Pharma all-time high quarterly cash flow from financing activities is $64.29 M
What is Lantern Pharma quarterly CFF year-on-year change?
Over the past year, LTRN quarterly cash flow from financing activities has changed by +$12.00 K (+100.00%)
What is Lantern Pharma TTM cash flow from financing activities?
The current TTM CFF of LTRN is -$433.30 K
What is the all time high TTM CFF for Lantern Pharma?
Lantern Pharma all-time high TTM cash flow from financing activities is $87.85 M
What is Lantern Pharma TTM CFF year-on-year change?
Over the past year, LTRN TTM cash flow from financing activities has changed by -$433.30 K (-100.00%)